InhaTarget Therapeutics at the European Society for Medical Oncology European Lung Cancer Congress 2023
InhaTarget Therapeutics is featured in this article on inhalable drugs published in The Wall Street Journal
InhaTarget Therapeutics is present at The Drug Delivery to the Lungs (DDL) 2022 Conference in Edinburgh